<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Colizzi M</submitter><pubmed_abstract>&lt;h4>Introduction&lt;/h4>Emerging evidence suggests that mental health symptoms in COVID-19 survivors are higher than expected, possibly indicating that such symptoms are more likely to develop post-infection than just persist as a residual component of the acute phase. It is thus imperative to investigate the potential development of a post-COVID mental health syndrome in the longer-term and identify its risk factors.&lt;h4>Material and methods&lt;/h4>A prospective study investigated mental health symptoms associated with COVID-19 and its determinants over a 12-month period following the disease onset in all consecutive adult inpatients and outpatients with COVID-19 attending a tertiary referral hospital from March to May 2020.&lt;h4>Results&lt;/h4>A total of 479 patients (female, 52.6%) were followed-up for 12 months after COVID-19 onset. Of them, 47.2% were still presenting with at least one symptom. While most symptoms subsided as compared to COVID-19 onset (all &lt;i>p&lt;/i> &lt; 0.001), a significant increase was observed only for symptoms of psychiatric disorders (10.2%) and lack of concentration and focus (20%; all &lt;i>p&lt;/i> &lt; 0.001). Patients presenting with symptoms related to multiple body systems 12 months after contracting COVID-19 (all &lt;i>p&lt;/i> ≤ 0.034) were more likely to suffer from mental health domain-related symptoms at follow-up. Also, a higher risk of presenting with lack of concentration and focus 12 months post infection was found in those suffering of psychiatric symptoms at COVID-19 onset (&lt;i>p&lt;/i> = 0.005).&lt;h4&gt;Conclusions&lt;/h4>Findings of this study may have important public health implications, as they underlie the increased need for mental health support in COVID-19 survivors.</pubmed_abstract><journal>Revista de psiquiatria y salud mental</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9212931</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors.</pubmed_title><pmcid>PMC9212931</pmcid><pubmed_authors>De Martino M</pubmed_authors><pubmed_authors>Balestrieri M</pubmed_authors><pubmed_authors>Colizzi M</pubmed_authors><pubmed_authors>Tascini C</pubmed_authors><pubmed_authors>Isola M</pubmed_authors><pubmed_authors>Gerussi V</pubmed_authors><pubmed_authors>Palese A</pubmed_authors><pubmed_authors>Peghin M</pubmed_authors><pubmed_authors>Bontempo G</pubmed_authors></additional><is_claimable>false</is_claimable><name>Mental health symptoms one year after acute COVID-19 infection: Prevalence and risk factors.</name><description>&lt;h4>Introduction&lt;/h4>Emerging evidence suggests that mental health symptoms in COVID-19 survivors are higher than expected, possibly indicating that such symptoms are more likely to develop post-infection than just persist as a residual component of the acute phase. It is thus imperative to investigate the potential development of a post-COVID mental health syndrome in the longer-term and identify its risk factors.&lt;h4>Material and methods&lt;/h4>A prospective study investigated mental health symptoms associated with COVID-19 and its determinants over a 12-month period following the disease onset in all consecutive adult inpatients and outpatients with COVID-19 attending a tertiary referral hospital from March to May 2020.&lt;h4>Results&lt;/h4>A total of 479 patients (female, 52.6%) were followed-up for 12 months after COVID-19 onset. Of them, 47.2% were still presenting with at least one symptom. While most symptoms subsided as compared to COVID-19 onset (all &lt;i>p&lt;/i> &lt; 0.001), a significant increase was observed only for symptoms of psychiatric disorders (10.2%) and lack of concentration and focus (20%; all &lt;i>p&lt;/i> &lt; 0.001). Patients presenting with symptoms related to multiple body systems 12 months after contracting COVID-19 (all &lt;i>p&lt;/i> ≤ 0.034) were more likely to suffer from mental health domain-related symptoms at follow-up. Also, a higher risk of presenting with lack of concentration and focus 12 months post infection was found in those suffering of psychiatric symptoms at COVID-19 onset (&lt;i>p&lt;/i> = 0.005).&lt;h4&gt;Conclusions&lt;/h4>Findings of this study may have important public health implications, as they underlie the increased need for mental health support in COVID-19 survivors.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Jun</publication><modification>2022-07-10T08:50:55.958Z</modification><creation>2022-07-10T08:50:55.958Z</creation></dates><accession>S-EPMC9212931</accession><cross_references><pubmed>35755492</pubmed><doi>10.1016/j.rpsm.2022.05.008</doi></cross_references></HashMap>